Company Intelligence

Abridge

Abridge provides enterprise-grade artificial intelligence solutions, delivering specialized Abridge Platform technology designed to optimize mission-critical workflows across enterprise software developers and digital transformation teams.

Headquarters
Pittsburgh, United States
Founded
2018
Status
Active
Products
1
Reports
8
Last reviewed
Aug 2026

Overview

What this company is, what it builds, and who it serves.

Abridge is a Healthcare AI company based in Pittsburgh, United States, founded in 2018.

Pittsburgh enterprise ambient AI platform for clinical conversations, documentation, and expanding decision support.

Verified founder profiles on Brel: Shiv Rao MD, Shiv Rao.

What it builds

Abridge Platform

Why It Matters

Abridge provides enterprise-grade artificial intelligence solutions, delivering specialized Abridge Platform technology designed to optimize mission-critical workflows across enterprise software developers and digital transformation teams.

Products

Products and platforms connected to this company.

Founders

People linked to this company in the Brel founder graph.

Ecosystem

How this company connects across the Brel AI intelligence graph.

Company

Abridge

Industry

Industries served

  • Digital Health

Capabilities

Abridge combines speech recognition, medical natural language understanding, and generative models tuned for clinical note formats across specialties. The Contextual Reasoning Engine…

Features

Enterprise-grade AI platform capturing clinical conversations to draft documentation for clinicians, revenue cycle, and nursing workflows, with expanding clinical decision support integrating…

Integrations

UpToDate integration referenced in the April 2026 release shows Abridge assembling a multi-publisher evidence layer rather than relying on a single content…

Country

United States

Official Resources

Official and developer links on file for this company.

Latest Developments

Verified developments and timeline notes on file.

  • April 15, 2026: Abridge announced content partnerships with NEJM Group and JAMA Network for conversation-shaped clinical decision support. Latest
  • Company founded 2018 · founded Source
  • Development 2018 · development Source
  • Partnership 2026 · partnership Source
  • Enterprise-grade AI platform capturing clinical conversations to draft documentation for clinicians, revenue cycle, and nursing workflows, with expanding clinical decision support integrating peer-reviewed evidence. Research

Frequently Asked Questions

What does Abridge do?

Abridge specializes in artificial intelligence, developing Abridge Platform to support enterprise software developers and digital transformation teams with scalable, production-grade technology.

Where is Abridge based and when was it founded?

Abridge is based in United States and was founded in 2018.

What are the main products offered by Abridge?

The flagship platform from Abridge is Abridge Platform, delivered primarily through b2b saas and enterprise api licensing.

Who are the primary target users of Abridge?

Abridge primarily serves enterprise software developers and digital transformation teams seeking reliable artificial intelligence implementations.

Sources & Verification

How this profile is verified and where the information comes from.

Verified
Last reviewed Aug 2026

Primary sources

Request a correction if you represent this company or believe information is inaccurate.